Ocugen (OCGN) Change in Acquisitions & Divestments (2017 - 2023)
Ocugen (OCGN) reported Change in Acquisitions & Divestments of $8.5 million for Q2 2023, down 5.56% quarter-over-quarter from $9.0 million in Q1 2023.
Ocugen (OCGN) Change in Acquisitions & Divestments (2017 - 2023) Analysis & Trends
Ocugen has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $8.5 million in Q2 2023.
- For the quarter ending Q2 2023, Change in Acquisitions & Divestments changed N/A year-over-year to $8.5 million; the trailing twelve-month figure through Mar 2024 stood at $8.5 million (down 5.56% YoY), and the FY2023 full-year result was $17.5 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q2 2023 stood at $8.5 million, down from $9.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $9.0 million in Q1 2023, with the low at $8.5 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 8.50 Mn |
| Jun 30, 2023 | 8.50 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Mar 31, 2018 | 900,000.00 |
| Mar 31, 2018 | 900,000.00 |
| Dec 31, 2017 | 891,000.00 |
| Dec 31, 2017 | 891,000.00 |